SCHEMBL22501708

SCHEMBL22501708

CCN(CC)c1ccc2c(C)c(CCNC(=O)NCc3ccccn3)c(=O)oc2c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.57
▸ KMT2A Q03164 4/20 0.57
▸ IGLV6-57 P01721 11/20 0.57
▸ KDM4E B2RXH2 3/20 0.53
▸ ALDH1A1 P00352 3/20 0.53
▸ GLA P06280 3/20 0.53
▸ ATM Q13315 3/20 0.53
▸ GAA P10253 2/20 0.53
▸ KLK7 P49862 1/20 0.53
▸ CASP1 P29466 2/20 0.51
▸ HTT P42858 2/20 0.51
▸ CASP7 P55210 2/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ LMNA P02545 1/20 0.51
▸ MAPT P10636 1/20 0.51
▸ THRB P10828 1/20 0.51
▸ L3MBTL1 Q9Y468 1/20 0.51
▸ SRC P12931 2/20 0.48
▸ HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24589986 0.89 IGLV6-57 (0.55) MEN1KMT2AIGLV6-57KDM4EALDH1A1
SCHEMBL22501633 0.87 IGLV6-57 (0.55) MEN1KMT2AIGLV6-57KDM4EALDH1A1
SCHEMBL24590096 0.87 IGLV6-57 (0.56) MEN1KMT2AIGLV6-57KDM4EALDH1A1
SCHEMBL24589969 0.87 IGLV6-57 (0.56) MEN1KMT2AIGLV6-57KDM4EALDH1A1
SCHEMBL24589957 0.87 IGLV6-57 (0.74) MEN1KMT2AIGLV6-57KDM4EALDH1A1
SCHEMBL24589900 0.86 IGLV6-57 (0.77) MEN1KMT2AIGLV6-57KDM4EALDH1A1
SCHEMBL24590171 0.86 IGLV6-57 (0.55) MEN1KMT2AIGLV6-57KDM4EALDH1A1
SCHEMBL24590075 0.86 MEN1 (0.62) MEN1KMT2AIGLV6-57KDM4EALDH1A1
SCHEMBL24590084 0.86 IGLV6-57 (0.57) MEN1KMT2AIGLV6-57KDM4EALDH1A1
SCHEMBL22501698 0.85 IGLV6-57 (0.62) MEN1KMT2AIGLV6-57KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE 2022-06-30 — — US disclosed
EP-3946604-A1 BENZOPYRANE AND IMIDAZOLE DERIVATIVES USEFUL FOR THE STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS The Scripps Research Institute (US) 2022-02-09 — — EP disclosed
WO-2020205683-A1 BENZOPYRANE AND IMIDAZOLE DERIVATIVES USEFUL FOR THE STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS THE SCRIPPS RESEARCH INSTITUTE (US) 2020-10-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220204485-A1 STABILIZATION OF AMYLOIDOGENIC IMMUNOGLOBULIN LIGHT CHAINS TTR, MAP1LC3B, SAAL1 MEN1 3542/4885KMT2A 4134/4885IGLV6-57 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback